Two consecutive phase II trials of biweekly oxaliplatin plus weekly 48-hour continuous infusion of nonmodulated high-dose 5-fluorouracil as first-line treatment for advanced colorectal cancer.
暂无分享,去创建一个
A. Carrato | A. Abad | A. Antón | A. Cervantes | E. Díaz-Rubio | M. Navarro | E. Aranda | J. Sastre | J. Manzano | E. Marcuello | M. Martínez-Villacampa | J. Guallar | B. Massutí